论文部分内容阅读
目的探讨了当前肝肾综合征患者的临床表现，并完善相应的治疗手段。方法将2010年1月~2012年6月入住我院的肝肾综合征38例患者随机分为两组。两组采用相同的常规治疗，但其中治疗组还另外采用特利加压素辅助治疗过程，而对照组则采用多巴胺按照3~5ug(kg.h)持续静脉泵治疗。在完成1w的治疗后，对两组患者治疗前后的尿量、尿素氮、血清肌酐等情况进行对比。结果两组的肝肾综合征患者的尿量、尿素氮、等水平得到明显改善，且治疗组取得更佳的治疗效果。结论特利加压素在临床上针对大多数肝肾综合征患者具有显著的成效，值得在临床上大力推广及应用。“,”Objective Explore the clinical manifestations and treatment of patients with hepatorenal syndrome. Methods 38 patients with the hepatorenal syndrome in our hospital from January 2010 to June 2012 were randomly divided into two groups (treatment and control groups). In addition to conventional therapy,the treatment group with terlipressin treatment,the control group receives dopamine in accordance with the 3~5ug (kg.h) continuous intravenous infusion therapy. By 1 week of treatment,compare the urine,blood urea nitrogen,serum creatinine changes in the two groups of patients before and after treatment. Results The urine output,blood urea nitrogen,serum creatinine levels were significantly improved in both of groups,but the treatment group was more significant in ef icacy. Conclusion Terlipressin with significant results in clinical hepatorenal syndrome patients,it is worth vigorously promotion and application in clinical practice.